Ajanta Pharma Ltd.

Financial

	Ajanta Pharma	Ipca Laboratories	Glenmark Pharma
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	74.0 .	43.0 .	13.0 .
Number of ANDA's Approved By USFDA	53.0 .	21.0 .	25.0 .
Domestic Sales Growth - YoY	15.6 %	7.6 %	10.1 %
R&D as a % of Total Sales	5.0 %	2.64 %	6.6 %
Financials
5 yr Average ROE	20.38 %	14.77 %	4.18 %
5yr average Equity Multiplier	1.34	1.47	1.88
5yr Average Asset Turnover Ratio	0.79	0.79	0.79
5yr Avg Net Profit Margin	19.43 %	12.85 %	2.73 %
Price to Book	9.11	5.57	4.72
P/E	37.33	51.14	0.0
5yr Avg Cash Conversion Cycle	-93.41 Days	62.7 Days	-121.67 Days
Inventory Days	61.2 Days	101.09 Days	40.44 Days
Days Receivable	52.69 Days	63.37 Days	36.38 Days
Days Payable	198.04 Days	112.44 Days	201.37 Days
5yr Average Interest Coverage Ratio	108.17	55.69	3.48
5yr Avg ROCE	25.98 %	18.16 %	16.29 %
5yr Avg Operating Profit Margin	27.51 %	19.9 %	15.62 %
5 yr average Debt to Equity	0.0	0.16	0.49
5yr CAGR Net Profit	11.78 %	-2.03 %	n/a
5yr Average Return on Assets	15.32 %	10.46 %	1.86 %
Shareholdings
Promoter Holding	66.26 %	44.72 %	46.65 %
Share Pledged by Promoters	12.61 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-4.22 %	-1.57 %	0.0
Change in Mutual Fund Holding (3 Yrs)	4.63 %	1.43 %	6.68 %

Business

	Ajanta Pharma	Ipca Laboratories	Glenmark Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 API 0 Generics 0 Branded Generics 0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 19.59 Pharmaceutical 0 Formulations 31.07 Glenmark generics 0 Branded Generics 49.34 Glenmark Pharma (Branded generics) 0	Product Wise Break-Up API 0 Pharmaceutical 0 Generics 0 Formulations 39.54 Branded Generics 0 Branded Generics 60.46
Segment Break-Up	Segment Break-Up Others 100	-	-
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 23.0 Pain 9.0 Neutraceuticals 0 Urology 0 Cough Preparations 0 Neuro Psychiatry 0 Gastro-Intestinal (GI) Products 0 Anti-Bacterials 0 Anti-Malarials 0 Cardiovasculars & Anti-Diabetics 0 0 Others 68.0	Therapeutic Area Wise Break-Up - Domestic Urology 4.0 Dermatology 6.0 Pain 52.0 Central Nervous System (CNS) 3.0 Cardiac Science 17.0 0 Gastro Intestinal 2.0 Cough and colds 4.0 Anti Malarials 3.0 Anti-bacterial 6.0 Neutraceuticals 1.0 Others 2.0	-
Location Wise Break-Up	Location Wise Break-Up India 32.52 Asia Pacific 24.94 Africa 21.57 USA 19.55 Asia (Excluding India) 0 Australia 0 CIS 0 Europe 0 Rest of the World 0 Latin America 0 North America 0 Others 1.42	Location Wise Break-Up Australia 4.05 India 46.34 CIS 3.35 Asia Pacific 6.08 Rest of the World 0 Europe 15.39 Africa 6.96 Asia Pacific 0 USA 17.83 Latin America 0 North America 0	Location Wise Break-Up Australia 0 India 31.4 CIS 0 Asia (Excluding India) 0 Rest of the World 22.11 Europe 21.54 Africa 0 Asia Pacific 0 USA 0 Latin America 0 North America 23.06 Others 1.89
Asset Break-Up	Asset Break-Up India 99.11 USA 0.51 Asia Pacific 0.29 Africa 0.08 Rest of the World 0 Europe 0 Latin America 0 North America 0 Others 0.01	-	Asset Break-Up India 50.13 Rest of the World 0 Europe 3.35 Africa 0 Asia Pacific 0 USA 0 Latin America 6.22 North America 40.3

Ajanta Pharma Ltd.

SIGN UP FOR FREE